nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—PTGS2—muscle cancer	0.479	1	CbGaD
Tetrahydrobiopterin—NOS3—Doxorubicin—muscle cancer	0.357	0.846	CbGbCtD
Tetrahydrobiopterin—PTGS2—Etoposide—muscle cancer	0.0648	0.154	CbGbCtD
Tetrahydrobiopterin—NOS3—Effects of Nitric Oxide—MB—muscle cancer	0.0135	0.378	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—hindlimb—muscle cancer	0.00908	0.177	CbGeAlD
Tetrahydrobiopterin—NOS3—appendage—muscle cancer	0.00779	0.152	CbGeAlD
Tetrahydrobiopterin—PAH—renal system—muscle cancer	0.00359	0.0701	CbGeAlD
Tetrahydrobiopterin—TPH1—head—muscle cancer	0.00306	0.0598	CbGeAlD
Tetrahydrobiopterin—PTGS2—hindlimb—muscle cancer	0.00288	0.0562	CbGeAlD
Tetrahydrobiopterin—TH—embryo—muscle cancer	0.00288	0.0562	CbGeAlD
Tetrahydrobiopterin—PTGS2—appendage—muscle cancer	0.00247	0.0482	CbGeAlD
Tetrahydrobiopterin—PAH—head—muscle cancer	0.0024	0.0469	CbGeAlD
Tetrahydrobiopterin—TH—renal system—muscle cancer	0.00218	0.0425	CbGeAlD
Tetrahydrobiopterin—NOS3—smooth muscle tissue—muscle cancer	0.00203	0.0397	CbGeAlD
Tetrahydrobiopterin—NOS3—renal system—muscle cancer	0.00196	0.0383	CbGeAlD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—TP73—muscle cancer	0.00168	0.0471	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—tendon—muscle cancer	0.00153	0.0299	CbGeAlD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—ANGPT2—muscle cancer	0.00152	0.0426	CbGpPWpGaD
Tetrahydrobiopterin—TH—head—muscle cancer	0.00146	0.0284	CbGeAlD
Tetrahydrobiopterin—NOS3—vagina—muscle cancer	0.00142	0.0277	CbGeAlD
Tetrahydrobiopterin—NOS3—head—muscle cancer	0.00131	0.0256	CbGeAlD
Tetrahydrobiopterin—NOS3—testis—muscle cancer	0.00127	0.0247	CbGeAlD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—TP73—muscle cancer	0.00123	0.0344	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Tryptophan metabolism—MDM2—muscle cancer	0.0011	0.0307	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—TP73—muscle cancer	0.000966	0.027	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—MYF6—muscle cancer	0.000921	0.0258	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—embryo—muscle cancer	0.00082	0.016	CbGeAlD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—CALD1—muscle cancer	0.000755	0.0211	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—FOXO4—muscle cancer	0.000739	0.0207	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—FOXO1—muscle cancer	0.000681	0.0191	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—smooth muscle tissue—muscle cancer	0.000645	0.0126	CbGeAlD
Tetrahydrobiopterin—PTGS2—renal system—muscle cancer	0.000621	0.0121	CbGeAlD
Tetrahydrobiopterin—NOS3—Angiogenesis—VEGFA—muscle cancer	0.000558	0.0156	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—FOXO1—muscle cancer	0.000546	0.0153	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—muscle cancer	0.000536	0.015	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—FOXO1—muscle cancer	0.000493	0.0138	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—tendon—muscle cancer	0.000485	0.00946	CbGeAlD
Tetrahydrobiopterin—NOS3—VEGFR1 specific signals—VEGFA—muscle cancer	0.00048	0.0134	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—bone marrow—muscle cancer	0.000469	0.00917	CbGeAlD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—CDKN2A—muscle cancer	0.000465	0.013	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—vagina—muscle cancer	0.00045	0.00878	CbGeAlD
Tetrahydrobiopterin—PTGS2—head—muscle cancer	0.000415	0.00811	CbGeAlD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—MYOD1—muscle cancer	0.000366	0.0103	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CD34—muscle cancer	0.000366	0.0103	CbGpPWpGaD
Tetrahydrobiopterin—Respiratory failure—Vincristine—muscle cancer	0.000361	0.0289	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—FOXO4—muscle cancer	0.00036	0.0101	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—FH—muscle cancer	0.000351	0.00983	CbGpPWpGaD
Tetrahydrobiopterin—Cardiovascular disorder—Etoposide—muscle cancer	0.000327	0.0262	CcSEcCtD
Tetrahydrobiopterin—Urine output increased—Vincristine—muscle cancer	0.000321	0.0257	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—muscle cancer	0.000316	0.00884	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—VEGFA—muscle cancer	0.000314	0.00878	CbGpPWpGaD
Tetrahydrobiopterin—Polyuria—Vincristine—muscle cancer	0.000293	0.0235	CcSEcCtD
Tetrahydrobiopterin—NOS3—SHP2 signaling—VEGFA—muscle cancer	0.000276	0.00771	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—S1P1 pathway—VEGFA—muscle cancer	0.000275	0.0077	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—FOXO1—muscle cancer	0.000266	0.00744	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—TP53—muscle cancer	0.000259	0.00723	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—FH—muscle cancer	0.000257	0.00718	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—muscle cancer	0.000243	0.00679	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—ANGPT2—muscle cancer	0.000239	0.00669	CbGpPWpGaD
Tetrahydrobiopterin—Neutropenia—Dactinomycin—muscle cancer	0.000233	0.0186	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—VEGFA—muscle cancer	0.000229	0.00642	CbGpPWpGaD
Tetrahydrobiopterin—Neutropenia—Vincristine—muscle cancer	0.000208	0.0166	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—FH—muscle cancer	0.000202	0.00564	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—MED12—muscle cancer	0.000198	0.00555	CbGpPWpGaD
Tetrahydrobiopterin—Pharyngitis—Dactinomycin—muscle cancer	0.000198	0.0158	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Vincristine—muscle cancer	0.000196	0.0156	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Vincristine—muscle cancer	0.000194	0.0156	CcSEcCtD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—TP53—muscle cancer	0.000194	0.00542	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—ENO2—muscle cancer	0.000181	0.00506	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—VEGFA—muscle cancer	0.00018	0.00504	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000177	0.00494	CbGpPWpGaD
Tetrahydrobiopterin—Respiratory failure—Methotrexate—muscle cancer	0.000175	0.014	CcSEcCtD
Tetrahydrobiopterin—Cardiovascular disorder—Doxorubicin—muscle cancer	0.00017	0.0136	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—VEGFA—muscle cancer	0.000169	0.00473	CbGpPWpGaD
Tetrahydrobiopterin—Neutropenia—Etoposide—muscle cancer	0.000169	0.0135	CcSEcCtD
Tetrahydrobiopterin—Infestation—Etoposide—muscle cancer	0.000161	0.0129	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Etoposide—muscle cancer	0.000161	0.0129	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Vincristine—muscle cancer	0.00016	0.0128	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—VEGFA—muscle cancer	0.000159	0.00446	CbGpPWpGaD
Tetrahydrobiopterin—Acute coronary syndrome—Etoposide—muscle cancer	0.000158	0.0127	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—ENO2—muscle cancer	0.000158	0.00442	CbGpPWpGaD
Tetrahydrobiopterin—Myocardial infarction—Etoposide—muscle cancer	0.000158	0.0126	CcSEcCtD
Tetrahydrobiopterin—Urine output increased—Methotrexate—muscle cancer	0.000156	0.0124	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—MED12—muscle cancer	0.000145	0.00406	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KIDINS220—muscle cancer	0.000145	0.00406	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—HMGA1—muscle cancer	0.000144	0.00402	CbGpPWpGaD
Tetrahydrobiopterin—Agitation—Vincristine—muscle cancer	0.000142	0.0114	CcSEcCtD
Tetrahydrobiopterin—Polyuria—Methotrexate—muscle cancer	0.000142	0.0114	CcSEcCtD
Tetrahydrobiopterin—Infection—Dactinomycin—muscle cancer	0.000141	0.0113	CcSEcCtD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—KIT—muscle cancer	0.00014	0.00392	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—FH—muscle cancer	0.00014	0.00391	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	0.000136	0.0038	CbGpPWpGaD
Tetrahydrobiopterin—Convulsion—Vincristine—muscle cancer	0.000134	0.0107	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—ENO2—muscle cancer	0.000132	0.0037	CbGpPWpGaD
Tetrahydrobiopterin—Mediastinal disorder—Etoposide—muscle cancer	0.00013	0.0104	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.000129	0.00361	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000129	0.0103	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—FOXO4—muscle cancer	0.000129	0.0036	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—muscle cancer	0.000128	0.00357	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Vincristine—muscle cancer	0.000127	0.0101	CcSEcCtD
Tetrahydrobiopterin—Infection—Vincristine—muscle cancer	0.000126	0.0101	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Vincristine—muscle cancer	0.000124	0.00993	CcSEcCtD
Tetrahydrobiopterin—Irritability—Methotrexate—muscle cancer	0.000119	0.00954	CcSEcCtD
Tetrahydrobiopterin—NOS3—Hemostasis—IGF2—muscle cancer	0.000116	0.00325	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000116	0.00926	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000115	0.00922	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—MED12—muscle cancer	0.000114	0.00319	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CDKN2A—muscle cancer	0.000114	0.00318	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain—Dactinomycin—muscle cancer	0.000112	0.00896	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Dactinomycin—muscle cancer	0.000112	0.00896	CcSEcCtD
Tetrahydrobiopterin—TH—Circadian rythm related genes—TP53—muscle cancer	0.000111	0.00311	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Etoposide—muscle cancer	0.00011	0.00877	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Vincristine—muscle cancer	0.000109	0.00874	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Etoposide—muscle cancer	0.000109	0.0087	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000108	0.00865	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000106	0.00849	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Dactinomycin—muscle cancer	0.000104	0.00835	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—ENO2—muscle cancer	0.000104	0.00291	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Vincristine—muscle cancer	0.000103	0.00828	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Etoposide—muscle cancer	0.000102	0.0082	CcSEcCtD
Tetrahydrobiopterin—Infection—Etoposide—muscle cancer	0.000102	0.00815	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Methotrexate—muscle cancer	0.000101	0.00808	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Methotrexate—muscle cancer	0.0001	0.00803	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Vincristine—muscle cancer	0.0001	0.008	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Vincristine—muscle cancer	0.0001	0.008	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Etoposide—muscle cancer	9.95e-05	0.00796	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Doxorubicin—muscle cancer	9.88e-05	0.0079	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Dactinomycin—muscle cancer	9.69e-05	0.00775	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Doxorubicin—muscle cancer	9.67e-05	0.00774	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Methotrexate—muscle cancer	9.63e-05	0.0077	CcSEcCtD
Tetrahydrobiopterin—Infestation—Methotrexate—muscle cancer	9.63e-05	0.0077	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Doxorubicin—muscle cancer	9.57e-05	0.00766	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—FOXO1—muscle cancer	9.51e-05	0.00266	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Vincristine—muscle cancer	9.32e-05	0.00746	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Dactinomycin—muscle cancer	9e-05	0.0072	CcSEcCtD
Tetrahydrobiopterin—Rash—Dactinomycin—muscle cancer	8.93e-05	0.00714	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Etoposide—muscle cancer	8.85e-05	0.00708	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Doxorubicin—muscle cancer	8.74e-05	0.00699	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Doxorubicin—muscle cancer	8.69e-05	0.00695	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Vincristine—muscle cancer	8.66e-05	0.00693	CcSEcCtD
Tetrahydrobiopterin—NOS3—Disease—ENO2—muscle cancer	8.6e-05	0.00241	CbGpPWpGaD
Tetrahydrobiopterin—Pharyngitis—Methotrexate—muscle cancer	8.58e-05	0.00686	CcSEcCtD
Tetrahydrobiopterin—Nausea—Dactinomycin—muscle cancer	8.41e-05	0.00673	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Etoposide—muscle cancer	8.38e-05	0.0067	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Vincristine—muscle cancer	8.37e-05	0.00669	CcSEcCtD
Tetrahydrobiopterin—Infestation—Doxorubicin—muscle cancer	8.33e-05	0.00667	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Doxorubicin—muscle cancer	8.33e-05	0.00667	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Etoposide—muscle cancer	8.1e-05	0.00648	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Etoposide—muscle cancer	8.1e-05	0.00648	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Doxorubicin—muscle cancer	8.1e-05	0.00648	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Vincristine—muscle cancer	8.04e-05	0.00644	CcSEcCtD
Tetrahydrobiopterin—Rash—Vincristine—muscle cancer	7.98e-05	0.00638	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Vincristine—muscle cancer	7.97e-05	0.00638	CcSEcCtD
Tetrahydrobiopterin—Headache—Vincristine—muscle cancer	7.93e-05	0.00634	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—MED12—muscle cancer	7.9e-05	0.00221	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HMGA1—muscle cancer	7.82e-05	0.00219	CbGpPWpGaD
Tetrahydrobiopterin—Mediastinal disorder—Methotrexate—muscle cancer	7.79e-05	0.00623	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Etoposide—muscle cancer	7.55e-05	0.00604	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Methotrexate—muscle cancer	7.52e-05	0.00602	CcSEcCtD
Tetrahydrobiopterin—Nausea—Vincristine—muscle cancer	7.52e-05	0.00601	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Doxorubicin—muscle cancer	7.43e-05	0.00594	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Doxorubicin—muscle cancer	7.37e-05	0.0059	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	7.25e-05	0.00203	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—KIT—muscle cancer	7.25e-05	0.00203	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ENO2—muscle cancer	7.2e-05	0.00202	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Etoposide—muscle cancer	7.01e-05	0.00561	CcSEcCtD
Tetrahydrobiopterin—NOS3—Disease—FOXO4—muscle cancer	7.01e-05	0.00196	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Etoposide—muscle cancer	6.78e-05	0.00542	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Doxorubicin—muscle cancer	6.74e-05	0.00539	CcSEcCtD
Tetrahydrobiopterin—Cough—Methotrexate—muscle cancer	6.56e-05	0.00525	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Methotrexate—muscle cancer	6.52e-05	0.00521	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Etoposide—muscle cancer	6.52e-05	0.00521	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Doxorubicin—muscle cancer	6.51e-05	0.00521	CcSEcCtD
Tetrahydrobiopterin—Rash—Etoposide—muscle cancer	6.46e-05	0.00517	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Etoposide—muscle cancer	6.46e-05	0.00517	CcSEcCtD
Tetrahydrobiopterin—Headache—Etoposide—muscle cancer	6.42e-05	0.00514	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Methotrexate—muscle cancer	6.4e-05	0.00512	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	6.36e-05	0.00509	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—PTGS2—muscle cancer	6.3e-05	0.00176	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Methotrexate—muscle cancer	6.14e-05	0.00491	CcSEcCtD
Tetrahydrobiopterin—Infection—Methotrexate—muscle cancer	6.1e-05	0.00488	CcSEcCtD
Tetrahydrobiopterin—Nausea—Etoposide—muscle cancer	6.09e-05	0.00487	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Methotrexate—muscle cancer	6.02e-05	0.00482	CcSEcCtD
Tetrahydrobiopterin—Agitation—Doxorubicin—muscle cancer	5.99e-05	0.00479	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Methotrexate—muscle cancer	5.96e-05	0.00477	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	5.72e-05	0.0016	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—FH—muscle cancer	5.72e-05	0.0016	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTCH1—muscle cancer	5.71e-05	0.0016	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MDM2—muscle cancer	5.71e-05	0.0016	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Doxorubicin—muscle cancer	5.68e-05	0.00455	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Doxorubicin—muscle cancer	5.64e-05	0.00451	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Methotrexate—muscle cancer	5.59e-05	0.00447	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Doxorubicin—muscle cancer	5.55e-05	0.00444	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	5.51e-05	0.00441	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—PTGS2—muscle cancer	5.5e-05	0.00154	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Methotrexate—muscle cancer	5.4e-05	0.00432	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Doxorubicin—muscle cancer	5.32e-05	0.00425	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Methotrexate—muscle cancer	5.3e-05	0.00424	CcSEcCtD
Tetrahydrobiopterin—Infection—Doxorubicin—muscle cancer	5.28e-05	0.00422	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Doxorubicin—muscle cancer	5.21e-05	0.00417	CcSEcCtD
Tetrahydrobiopterin—NOS3—Disease—FOXO1—muscle cancer	5.18e-05	0.00145	CbGpPWpGaD
Tetrahydrobiopterin—Skin disorder—Doxorubicin—muscle cancer	5.16e-05	0.00413	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Methotrexate—muscle cancer	5.02e-05	0.00402	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FOXO4—muscle cancer	4.91e-05	0.00137	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—VEGFA—muscle cancer	4.87e-05	0.00136	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain—Methotrexate—muscle cancer	4.85e-05	0.00388	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Methotrexate—muscle cancer	4.85e-05	0.00388	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	4.84e-05	0.00387	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TP53—muscle cancer	4.83e-05	0.00135	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CNR1—muscle cancer	4.82e-05	0.00135	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Doxorubicin—muscle cancer	4.68e-05	0.00374	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—PTGS2—muscle cancer	4.61e-05	0.00129	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal disorder—Doxorubicin—muscle cancer	4.59e-05	0.00367	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Methotrexate—muscle cancer	4.52e-05	0.00362	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Doxorubicin—muscle cancer	4.35e-05	0.00348	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	4.35e-05	0.00122	CbGpPWpGaD
Tetrahydrobiopterin—Body temperature increased—Doxorubicin—muscle cancer	4.2e-05	0.00336	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Doxorubicin—muscle cancer	4.2e-05	0.00336	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Methotrexate—muscle cancer	4.2e-05	0.00336	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Methotrexate—muscle cancer	4.06e-05	0.00325	CcSEcCtD
Tetrahydrobiopterin—NOS3—Disease—KIT—muscle cancer	3.95e-05	0.0011	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IGF2—muscle cancer	3.94e-05	0.0011	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Doxorubicin—muscle cancer	3.92e-05	0.00313	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Methotrexate—muscle cancer	3.9e-05	0.00312	CcSEcCtD
Tetrahydrobiopterin—Rash—Methotrexate—muscle cancer	3.87e-05	0.0031	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Methotrexate—muscle cancer	3.87e-05	0.00309	CcSEcCtD
Tetrahydrobiopterin—Headache—Methotrexate—muscle cancer	3.85e-05	0.00308	CcSEcCtD
Tetrahydrobiopterin—NOS3—Hemostasis—TP53—muscle cancer	3.68e-05	0.00103	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Methotrexate—muscle cancer	3.65e-05	0.00292	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Doxorubicin—muscle cancer	3.64e-05	0.00291	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FOXO1—muscle cancer	3.63e-05	0.00101	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTGS2—muscle cancer	3.62e-05	0.00101	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ENO2—muscle cancer	3.52e-05	0.000984	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Doxorubicin—muscle cancer	3.52e-05	0.00281	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Doxorubicin—muscle cancer	3.38e-05	0.0027	CcSEcCtD
Tetrahydrobiopterin—Rash—Doxorubicin—muscle cancer	3.35e-05	0.00268	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Doxorubicin—muscle cancer	3.35e-05	0.00268	CcSEcCtD
Tetrahydrobiopterin—Headache—Doxorubicin—muscle cancer	3.33e-05	0.00266	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	3.28e-05	0.000919	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—MED12—muscle cancer	3.23e-05	0.000904	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HMGA1—muscle cancer	3.2e-05	0.000894	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Doxorubicin—muscle cancer	3.16e-05	0.00253	CcSEcCtD
Tetrahydrobiopterin—NOS3—Disease—MDM2—muscle cancer	3.11e-05	0.000869	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTGS2—muscle cancer	3e-05	0.000838	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ENO2—muscle cancer	2.95e-05	0.000824	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FOXO4—muscle cancer	2.87e-05	0.000802	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KIT—muscle cancer	2.76e-05	0.000773	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTGS2—muscle cancer	2.51e-05	0.000702	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MDM2—muscle cancer	2.18e-05	0.000609	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FOXO1—muscle cancer	2.12e-05	0.000592	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—VEGFA—muscle cancer	1.65e-05	0.000462	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KIT—muscle cancer	1.61e-05	0.000451	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MDM2—muscle cancer	1.27e-05	0.000356	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TP53—muscle cancer	1.25e-05	0.000349	CbGpPWpGaD
